PlainVisa
2026 data Public-data reference Official source

GC Therapeutics, Inc.

A DOL Labor Condition Application record spanning FY2024–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
3
DOL-certified
100%
Median offered wage
$130,000

Cambridge, MA NAICS: 541714

The DOL filing record for GC Therapeutics, Inc.

U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming GC Therapeutics, Inc. from FY2024 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

GC Therapeutics, Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

3 52221st of 122824 higher than 70,603 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2024–FY2026

According to U.S. Department of Labor OFLC LCA disclosure files (FY2024–FY2026). Headquartered in Cambridge, MA. Methodology.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

LCA filing shape · GC Therapeutics, Inc.

Derived from this employer's disclosed LCAs on file (FY2024–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $110,000$170,000 .

Title concentration

  • Principal Research Associate 2 · 66.7% · $110,000
  • Senior Scientist III 1 · 33.3% · $170,000

Worksite counties

  • CAMBRIDGE CITY, MA 2 · 100%

Local thin filer

GC Therapeutics, Inc. (Cambridge, MA) has 3 disclosed LCA s with worksites in a single state on this extract. Top title: Principal Research Associate. Small-N percentages swing hard on one withdrawn filing.

Recent LCA Filings

Latest H-1B labor condition applications filed by GC Therapeutics, Inc.

Job Title Location Salary Status Year
Senior Scientist III Cambridge, MA $170,000 Certified FY2026
Principal Research Associate Cambridge, MA $110,000 Certified FY2025
Principal Research Associate Cambridge, MA $110,000 Certified FY2024

Nationwide peers near GC Therapeutics, Inc.'s 3-LCA band

Cross-state DOL neighbors for GC Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MA.

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($130,000 here).

What People Ask

What is GC Therapeutics, Inc.'s H-1B LCA filing count?

GC Therapeutics, Inc. is listed in 3 DOL Labor Condition Application filings covering 3 listed worker positions from FY2024 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does GC Therapeutics, Inc.'s LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, GC Therapeutics, Inc. ranks #40445 by total LCA filing count (3 filings). 70,603 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

How often are GC Therapeutics, Inc.'s LCAs certified by the Labor Department?

GC Therapeutics, Inc. has a 100% DOL certification rate, with 3 out of 3 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What does GC Therapeutics, Inc. list as the offered wage on its LCAs?

The average offered wage listed in GC Therapeutics, Inc.'s LCAs is $130,000. Listed wages range from $110,000 to $170,000 and are not verified actual compensation.

What roles does GC Therapeutics, Inc. file the most H-1B LCAs for?

The top job titles in GC Therapeutics, Inc.'s LCA filing records include Principal Research Associate, Senior Scientist III. The most common listed title is Principal Research Associate with 2 LCA filings at an average listed offered wage of $110,000. This does not establish actual job openings, hiring, or approved petitions.

Where is GC Therapeutics, Inc. located?

GC Therapeutics, Inc. is headquartered in Cambridge, MA.

Is GC Therapeutics, Inc. H-1B dependent?

No, GC Therapeutics, Inc. is not classified as H-1B dependent.

What is the year-over-year trend in GC Therapeutics, Inc.'s LCA filings?

GC Therapeutics, Inc. is listed in 1 LCA filings in FY2024 and 1 in FY2026. The average listed offered wage increased from $110,000 to $170,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with GC Therapeutics, Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.

What to do with this profile

Use the DOL LCA record for GC Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.